Scientists track Cancer's DNA trail during surgery
NCT ID NCT03435536
Summary
This study aimed to understand if the act of surgically removing a pancreatic tumor causes tumor DNA to be released into the patient's bloodstream. Researchers tracked 35 patients with operable pancreatic cancer, taking blood samples before, during, and for a year after surgery. The goal was to see if these DNA levels could help doctors better monitor patients and predict outcomes after the tumor is removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.